Transfusion medicine and safety

Biologicals

Volumn 37, Issue 2, 2009, Pages 62-70

  Dodd, Roger ^a   Kurt Roth, W ^b   Ashford, Paul ^c   Dax, Elizabeth M ^d   Vyas, Girish ^e  

^a HOLLAND LABORATORY   (United States)

^b GFE Blut mbH   (Germany)

^c ICCBA Inc   (United States)

^d National Serology Reference Laboratory   (Australia)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hemovigilance; Microbial risk in transfusion; Standards for transfusion safety; Virological screening assays

Indexed keywords

NUCLEIC ACID;

ARTICLE; BACTERIUM CONTAMINATION; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; RISK REDUCTION; SAFETY; SCREENING; STANDARDIZATION; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; EQUIPMENT CONTAMINATION; HEMATOLOGIC TESTS; HUMANS; INTERNATIONAL COOPERATION; MICROBIOLOGICAL TECHNIQUES; MODELS, BIOLOGICAL; REFERENCE STANDARDS; SAFETY; VIRUS DISEASES;

BACTERIA (MICROORGANISMS); HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 63249101713     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.01.006     Document Type: Article

References (16)

1. Eder A.F., Kennedy J.M., Dy B.A., Notari E.P., Weis J.W., Fang C.T., et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 47 (2007) 1134-1142
2. de Korte D., Curvers J., de Kort W.L., Hoekstra T., van der Poel C.L., Beckers E.A., et al. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 46 (2006) 476-485
3. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01702.html
4. Webert K.E., Cserti C.M., Hannon J., Lin Y., Pavenski K., Pendergrast J.M., et al. Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev 22 (2008) 1-34
5. Ashford P., Distler P., Gee A., Lankester A., Larsson S., Feller I., et al. Standards for the terminology and labeling of cellular therapy products. Transfusion 47 (2007) 1319-1327
6. Wendel S. Rational testing for transmissible diseases. ISBT Sci Ser 2 (2007) 19-24
7. Dax E.M., and Walker S. Advances in quality assurance of laboratory testing for transfusion safety. In: Dax E.M., Farrugia A., and Vyas G. (Eds). Advances in transfusion safety - vol. IV. Dev Biol (Basel) 127 (2007) 183-195 Basel, Karger
8. Busch M.P. Evolving approaches to estimate risks of transfusion transmitted viral infections: incidence-window period model after 10 years. In: Dax E.M., Farrugia A., and Vyas G. (Eds). Advances in transfusion safety - vol. IV. Dev Biol (Basel) 127 (2007) 87-112 Basel, Karger
9. O'Brien S.F., Yi Q.L., Fan W., Scalia V., Kleinman S.H., and Vamvakas E.C. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian blood services. Transfusion 47 2 (2007 Feb) 316-325
10. World Health Organization. HIV test kit evaluations. Available from:. http://www.who.int/diagnostics_laboratory/evaluations/hiv/en/
11. Vyas G.N. Participating in the evolution of transfusion medicine from a dispensary into a discipline. Transfus Med Rev 22 (2008) 162-167
12. Alter H.J., and Klein H.G. The hazards of blood transfusion in historical perspective. Blood 112 (2008) 2617-2626
13. Vyas G.N., and Perkins H.A. Non-B posttransfusion hepatitis associated with hepatitis B core antibodies in donor blood. N Engl J Med 306 (1982) 749-750
14. Reesink H.W., Engelfriet C.P., Henn G., Mayr W.R., Delage G., Bernier F., et al. Occult hepatitis B infection in blood donors. Vox Sang 94 (2008) 153-166
15. Silva C.M., Costi C., Costa C., Michelon C., Oravec R., Ramos A.B., et al. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. J Infect 51 (2005) 24-29
16. Anderson R.E., Winkelstein W., Blum H.E., and Vyas G.N. Hepatitis B virus infection in the acquired immune deficiency syndrome (AIDS). In: Vyas G.N., Dienstag J.L., and Hoofnagle J.H. (Eds). Viral hepatitis and liver disease (1984), Grune & Stratton, Orlando 339-343